의약품용 임상시험 공급 및 물류 시장 : 단계별, 부문별, 치료 분야별 - 세계 예측(2025-2030년)

The Clinical Trial Supply & Logistics for Pharmaceutical Market was valued at USD 22.73 billion in 2023, expected to reach USD 24.48 billion in 2024, and is projected to grow at a CAGR of 7.75%, to USD 38.34 billion by 2030.

The Clinical Trial Supply & Logistics market in the pharmaceutical sector is defined by the operations and processes concerned with the management, transportation, and storage of investigational medicinal products and other related materials essential for conducting clinical trials. The necessity of an efficient supply and logistics system is accentuated by the growing complexity of clinical trials, geographic expansion, and the need for compliance with stringent regulatory norms. Key applications span from managing supply chains for large-scale global trials to ensuring the timely distribution and integrity of products across various trial sites. The end-use scope primarily involves pharmaceutical companies, contract research organizations (CROs), and healthcare institutions dedicated to developing new medicines and therapies.

The market is witnessing positive growth due to factors such as an increase in clinical trials, outsourcing of research activities, and technological advancements in supply chain management systems. Digitalization and adoption of technologies like blockchain and IoT offer significant opportunities for enhancing transparency, efficiency, and data accuracy in supply chain management. Emerging opportunities lie in the integration of artificial intelligence for predictive analytics and risk management, and in personalized medicine logistics, tailored to specific trial requirements. However, challenges include high costs, stringent regulatory requirements, fluctuating supply chain dynamics post-pandemic, and the complexity of managing high-value, temperature-sensitive products across borders.

Innovation and research areas with substantial potential include the development of adaptive logistics models that can swiftly respond to protocol changes in trials, and advanced forecasting tools to predict supply chain risks and demands accurately. Furthermore, fostering collaborations between logistics firms and technology providers to develop customized solutions that address specific trial needs can drive market growth. While the market is rapidly evolving with technological advancements, the inherent complexity and regulatory hurdles necessitate ongoing vigilance and adaptability from market participants to sustain in a competitive environment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Trial Supply & Logistics for Pharmaceutical Market

The Clinical Trial Supply & Logistics for Pharmaceutical Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
  • Increased Focus on Drug Development
  • Globalization of Clinical Trials and Harmonization of Regulations
• Market Restraints
  • Increased Cost of Drug Development and Clinical Trials
• Market Opportunities
  • Outsourcing of Clinical Trial Activity
  • Increased Focus on Generics and Biologics
  • Regulatory Approvals in Emerging Markets
• Market Challenges
  • Logistics Challenges Across Nations

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Trial Supply & Logistics for Pharmaceutical Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Trial Supply & Logistics for Pharmaceutical Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Trial Supply & Logistics for Pharmaceutical Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Trial Supply & Logistics for Pharmaceutical Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Trial Supply & Logistics for Pharmaceutical Market

A detailed market share analysis in the Clinical Trial Supply & Logistics for Pharmaceutical Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Trial Supply & Logistics for Pharmaceutical Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Trial Supply & Logistics for Pharmaceutical Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supply & Logistics for Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include Catalent, Inc., Eurofins Scientific SE, Biocair International Limited, PCI Pharma Services, SIRO Clinpharm Private Limited, Marken, Parexel International Corporation, Infosys Limited, Clinigen Group PLC, Movianto, DHL International GmbH by Deutsche Post AG, ICON PLC, Seveillar Clinical Trial Supplies Pvt. Ltd., Thermo Fisher Scientific, Inc., Bilcare Limited, Lonza Group, KLIFO A/S, Almac Group, FedEx Corporation, N-Side, and AmerisourceBergen Corporation.

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supply & Logistics for Pharmaceutical Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Phase, market is studied across BA/BE Studies, Phase I, Phase II, Phase III, and Phase IV.
• Based on Sector, market is studied across Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, and Clinical Trial Supply Chain Management.
• Based on Therapeutic Area, market is studied across Blood Disorders, Digestive System Diseases, Infectious and Immune System Diseases, Neurological and Mental Disorders, and Oncology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
    • 5.1.1.2. Increased Focus on Drug Development
    • 5.1.1.3. Globalization of Clinical Trials and Harmonization of Regulations
  • 5.1.2. Restraints
    • 5.1.2.1. Increased Cost of Drug Development and Clinical Trials
  • 5.1.3. Opportunities
    • 5.1.3.1. Outsourcing of Clinical Trial Activity
    • 5.1.3.2. Increased Focus on Generics and Biologics
    • 5.1.3.3. Regulatory Approvals in Emerging Markets
  • 5.1.4. Challenges
    • 5.1.4.1. Logistics Challenges Across Nations
• 5.2. Market Segmentation Analysis
  • 5.2.1. Phase: Rising inclination toward Phase III trials owing to the need for exponential utility of clinical trial supply & logistics
  • 5.2.2. Therapeutic Area: Exponential utility of clinical trial supply & logistics to cater to the ever-growing oncology R&D activities
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase

• 6.1. Introduction
• 6.2. BA/BE Studies
• 6.3. Phase I
• 6.4. Phase II
• 6.5. Phase III
• 6.6. Phase IV

7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector

• 7.1. Introduction
• 7.2. Clinical Trial Logistics and Distributions
• 7.3. Clinical Trial Manufacturing Services
• 7.4. Clinical Trial Supply Chain Management

8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area

• 8.1. Introduction
• 8.2. Blood Disorders
• 8.3. Digestive System Diseases
• 8.4. Infectious and Immune System Diseases
• 8.5. Neurological and Mental Disorders
• 8.6. Oncology

9. Americas Clinical Trial Supply & Logistics for Pharmaceutical Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Clinical Trial Supply & Logistics for Pharmaceutical Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Trial Supply & Logistics for Pharmaceutical Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
  • 12.3.2. Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
  • 12.3.3. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China

Companies Mentioned

• 1. Catalent, Inc.
• 2. Eurofins Scientific SE
• 3. Biocair International Limited
• 4. PCI Pharma Services
• 5. SIRO Clinpharm Private Limited
• 6. Marken
• 7. Parexel International Corporation
• 8. Infosys Limited
• 9. Clinigen Group PLC
• 10. Movianto
• 11. DHL International GmbH by Deutsche Post AG
• 12. ICON PLC
• 13. Seveillar Clinical Trial Supplies Pvt. Ltd.
• 14. Thermo Fisher Scientific, Inc.
• 15. Bilcare Limited
• 16. Lonza Group
• 17. KLIFO A/S
• 18. Almac Group
• 19. FedEx Corporation
• 20. N-Side
• 21. AmerisourceBergen Corporation